PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,734,844 | -23.4% | 154,330 | 0.0% | 0.10% | -19.5% |
| Q2 2023 | $6,184,003 | -1.9% | 154,330 | -0.0% | 0.12% | -7.8% |
| Q1 2023 | $6,301,064 | +14.4% | 154,400 | +8.2% | 0.13% | +8.5% |
| Q4 2022 | $5,510,033 | -27.4% | 142,710 | 0.0% | 0.12% | -32.2% |
| Q3 2022 | $7,591,000 | -8.8% | 142,710 | 0.0% | 0.17% | -4.4% |
| Q2 2022 | $8,320,000 | -23.5% | 142,710 | +0.1% | 0.18% | -6.2% |
| Q1 2022 | $10,876,000 | +26.8% | 142,505 | 0.0% | 0.19% | +38.6% |
| Q4 2021 | $8,575,000 | +22.2% | 142,505 | +13.7% | 0.14% | +12.9% |
| Q3 2021 | $7,020,000 | +0.3% | 125,350 | +8.7% | 0.12% | +0.8% |
| Q2 2021 | $6,999,000 | -6.2% | 115,335 | +8.4% | 0.12% | -11.5% |
| Q1 2021 | $7,460,000 | +17.1% | 106,440 | -0.0% | 0.14% | +14.9% |
| Q4 2020 | $6,372,000 | – | 106,490 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |